Motorists risk being hit with an eye-watering £1,000 fine if they fail to declare certain conditions to the DVLA ...

In this Healio Video Perspective from Retina 2025, Allen C. Ho, MD, discusses the growing promise of optogenetic therapy in treating patients with retinal disease.

Hanaa Mahdi Saleh Ali lived in a world without a clear vision. At one point, she lost all hope to see again — until she flew ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds were identified using a virtual screening approach. Two new ...

A drug that receives Fast Track designation may benefit from more frequent interactions with the FDA throughout drug development. In addition, the Fast Track program allows for Accelerated Approval ...

a clinical-stage biopharmaceutical company developing treatments for retinitis pigmentosa, cataracts and other diseases caused by oxidative stress, today announced that the U.S. Food and Drug ...

Scientists have identified two non-retinoid compounds that may be able to treat retinitis pigmentosa (RP), a group of inherited eye diseases that cause blindness. The compounds were discovered by ...

The FDA granted rare pediatric disease designation to VG901 for retinitis pigmentosa. An independent data safety monitoring board approved dose escalation in an ongoing trial assessing the therapy.